Please wait a minute...
European Journal of Gynaecological Oncology  2021, Vol. 42 Issue (1): 174-178    DOI: 10.31083/j.ejgo.2021.01.2209
Case Report Previous articles | Next articles
Port site implantation of clear cell carcinoma after laparoscopic ovarian cystectomy
Joseph J. Noh1, Kyue-Hee Choi2, Hyun-Soo Kim2, Jeong-Won Lee1, *()
1Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 06351 Seoul, South Korea
2Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 06351 Seoul, South Korea
Download:  PDF(1591KB)  ( 33 ) Full text   ( 3 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Despite the fact that laparoscopic surgery has clearly shown benefits in patients with benign ovarian tumor, concerns remain regarding port site metastasis especially when final pathology reveals malignancy. Port site metastasis has been reported in early stages of malignant diseases. However, to our knowledge there are no reports of port site implantation of malignant cells after laparoscopic surgery for benign disease. We present a 39-year-old woman who had undergone laparoscopic ovarian cystectomy for benign disease, and developed clear cell carcinoma at the site of trocar insertion 11 months after the initial operation. It is possible that the cancer was missed at the time of the initial surgery. Numerous factors have been suggested in the development of port site metastasis including aerosolization of tumor cells, lack of local immune response by the host and unskilled surgical techniques. A careful preoperative evaluation and meticulous laparoscopic maneuvers are the best way to prevent such occurrence.
Key words:  Laparoscopy      Port site metastasis      Clear cell carcinoma      Ovarian cancer     
Submitted:  03 August 2020      Revised:  18 October 2020      Accepted:  20 October 2020      Published:  15 February 2021     
*Corresponding Author(s):  Jeong-Won Lee     E-mail:  garden.lee@samsung.com

Cite this article: 

Joseph J. Noh, Kyue-Hee Choi, Hyun-Soo Kim, Jeong-Won Lee. Port site implantation of clear cell carcinoma after laparoscopic ovarian cystectomy. European Journal of Gynaecological Oncology, 2021, 42(1): 174-178.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2021.01.2209     OR     https://ejgo.imrpress.com/EN/Y2021/V42/I1/174

[1] Tadahiro Shoji, Kotoka Kikuchi, Hayato Kogita, Nanako Jonai, Hidetoshi Tomabechi, Akiko Kudoh, Eriko Takatori, Takayuki Nagasawa, Masahiro Kagabu, Tsukasa Baba. New treatment strategy for ovarian cancer with a BRCA gene mutation[J]. European Journal of Gynaecological Oncology, 2021, 42(1): 1-9.
[2] Joseph J. Noh, Tae-Joong Kim. The current evidence for the use of minimally-invasive surgery in endometrial cancer[J]. European Journal of Gynaecological Oncology, 2021, 42(1): 18-25.
[3] Sigit Purbadi, Kade Yudi Saspriyana. Primary debulking surgery of advanced epithelial ovarian cancer in developing countries: challenges and expectations[J]. European Journal of Gynaecological Oncology, 2021, 42(1): 26-29.
[4] Ece Gumusoglu, Tuba Gunel, Mohammad Kazem Hosseini, Nogayhan Seymen, Taylan Senol, Uğur Sezerman, Samet Topuz, Kılıç Aydınlı. The importance of dysregulated miRNAs on ovarian cysts and epithelial ovarian cancer[J]. European Journal of Gynaecological Oncology, 2021, 42(1): 66-72.
[5] Min Jong Song, Suk Il Jang, Hyon Jee Yoon, Eun Young Ki, Joon Mo Lee, Soo Young Hur. Classical HLA class I antigen downregulation and abnormal HLA-G expression in ovarian cancer[J]. European Journal of Gynaecological Oncology, 2021, 42(1): 129-138.
[6] Azusa Kimura, Kenro Chikazawa, Ken Imai, Ito Takaki, Tomoyuki Kuwata, Ryo Konno. Cesarean scar perforation in laparoscopic hysterectomy for endometrial cancer: a case report[J]. European Journal of Gynaecological Oncology, 2021, 42(1): 179-182.
[7] Francesco Plotti, Bartolone Martina, Terranova Corrado, Luvero Daniela, Scaletta Giuseppe, Gatti Alessandra, Benedetti Panici Pierluigi, Angioli Roberto. Role of human epididymis protein 4 (HE4) as predictor of response to platinum based chemotherapy: a systematic review of literature[J]. European Journal of Gynaecological Oncology, 2020, 41(6): 889-896.
[8] Irina Esteves-Krasteva, José Ángel Minguez, José María Aramendía, Marta Santisteban, Fernando Martinez-Regueira, Gabriel Zozaya-Larequi, Juan Luis Alcázar, Matías Jurado. Complete cytoreductive surgery, the key factor for survival in advanced ovarian cancer. Experience of an intermediate volume hospital[J]. European Journal of Gynaecological Oncology, 2020, 41(6): 906-912.
[9] Sefa Kurt, Selim Kandemir, Onur Yavuz, Meral Koyuncuoglu, Emine Cagnur Ulukus, Murat Celiloglu. Persistent tubal epithelium in ovaries after salpingectomy[J]. European Journal of Gynaecological Oncology, 2020, 41(6): 919-923.
[10] Haci Ozturk Sahin, Zelal Aydin, Ibrahim Ugras Toktas, Cetin Toraman, Ilkbal Temel Yuksel, Alper Seyhan, Ozgur Akbayir. Clinical and prognostic value of pre-operative systemic inflammatory markers in clinical course and prognosis of ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(6): 924-930.
[11] Jeong In Choi, Jae Hong Sang, Soo-Ho Chung. Is laparotomy better than laparoscopic surgery in early cervical cancer?[J]. European Journal of Gynaecological Oncology, 2020, 41(6): 949-951.
[12] Hiroshi Yoshida, Megumi Yamamoto, Hiroyuki Shigeta, Miwa Yasaka, Hiroko Machida, Masae Ikeda, Masako Shida, Takeshi Hirasawa, Mikio Mikami. Usefulness of laparoscopic restaging surgery for patients diagnosed with apparent early ovarian/fallopian tubal cancer by a prior surgery, a case control observational study in a single institute in Japan[J]. European Journal of Gynaecological Oncology, 2020, 41(6): 960-968.
[13] Yuji Tanaka, Yusuke Shimizu, Ai Ikki, Kota Okamoto, Atsushi Fusegi, Makoto Nakabayashi, Makiko Omi, Tomoko Kurita, Terumi Tanigawa, Yoichi Aoki, Sachiho Netsu, Mayu Yunokawa, Hidetaka Nomura, Maki Matoda, Sanshiro Okamoto, Kohei Omatsu, Hiroyuki Kanao. Laparoscopic ureteral reconstruction in gynaecological recurrent cancer surgeries: an initial case series study[J]. European Journal of Gynaecological Oncology, 2020, 41(6): 975-981.
[14] Fatih Kose, Songül Alemdaroğlu, Hüseyin Mertsoylu, Ali Ayberk Beşen, Ozan Cem Güler, Seda Yüksel Şimşek, Gürcan Erbay, Cem Önal, Hüsnü Çelik. Clinical characteristics of relapsed ovarian cancer patients with striking response to the bevacizumab at first relapse[J]. European Journal of Gynaecological Oncology, 2020, 41(6): 989-995.
[15] R van de Vrie, E van Werkhoven, M J Rutten, J D Asseler, H S van Meurs, D E Werter, M R Buist, A.H. Zwinderman, C A R Lok, P.M.M. Bossuyt, G G Kenter, P Tajik. Validation of a treatment-selection rule for patients with advanced stage ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(6): 1023-1030.
No Suggested Reading articles found!